Japan Panel Recommends Easing Rules To Allow Access To New Drugs
This article was originally published in PharmAsia News
Executive Summary
Japan's Council for Regulatory Reform has recommended the government soften some of its regulations to ease patient access to get treatment with drugs not yet approved for their conditions.